SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?


To: Joe Copia who wrote (755)10/30/1998 11:43:00 PM
From: STRTYZ  Respond to of 1286
 
Some good info on shell mergers,The Acquisition Process,ect...

shellcorp.com

Tim



To: Joe Copia who wrote (755)10/31/1998 12:15:00 AM
From: wonk  Read Replies (1) | Respond to of 1286
 
Joe:

You wrote:

National Boston is "using" FGRX shell to be listed. After listing they will throw that shell away as a dividend, albiet worthless.

Yet, in the October 5th PR:

Daniel Hoyng, president of National Boston stated: ''I back Bob and the shareholders 100%. All appropriate avenues will be followed to conclusion. I look forward to a long lasting relationship with Bob and Fragrance Express.''

and the President of FGRX said:

Robert M. Bartlett, stated Monday: ''We have had a lot of phone inquiries today about the CUSIP situation. The upcoming merger with National Boston will not impede any recourse our stockholders and the company has against CUSIP for their error. I need to reiterate that the company's present CUSIP number is correct.

''Also, I want to point out that the company has published its financial information in Standard and Poor's Corporate Records. With a $2.93 per share book value, as published, today's activity is heading in the right direction.''
#reply-5916767

Two questions immediately come to mind:

If FGRX is/was a worthless shell, why would Hoyng permit the PR to go out in this form?

If FGRX is/was a worthless shell, is the $2.93 book value bogus?

At this moment in time, this PR looks suspiciously like the infamous ICVI/MTEI $200 million in assets/$2.85 per share PR: and we all know what happened there. #reply-4814082

ww



To: Joe Copia who wrote (755)10/31/1998 7:12:00 AM
From: xbrent  Read Replies (1) | Respond to of 1286
 
Fragrance is an operating company with assets. They presently have four business locations in FLA. I do think that the primiary vehicles for a substantial increase in shareholder value reside in National Boston, Bontempi and the Anti microbial. IMO, Fragrance is a small developing company but a two sources have confirmed that they do have substantial assets. As I have maintained, none of us a certain as to what the vital statistics are in this situation and need clarification from the Company.